Appili Logo.png
Researchers Publish Manuscript on the Prevention and Emergency Response to Tularemia Outbreaks
12 mars 2024 07h12 HE | Appili Therapeutics Inc.
HALIFAX, Nova Scotia, March 12, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for...
Dyadic Logo Current.jpg
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
21 févr. 2024 08h30 HE | Dyadic International, Inc.
JUPITER, Fla. and NES-ZIONA, Israel, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company specializing in advanced...
Fairfield Market Research Logo (1).JPG
Global Biodefense Market Revenue Will Attain US$24.5 Bn by the End of 2030, Forecasts Fairfield Market Research in a New Report
27 avr. 2023 12h56 HE | Fairfield Consultancy Services OPC Pvt Ltd
London, April 27, 2023 (GLOBE NEWSWIRE) -- Projected to demonstrate a healthy CAGR of 6.3% between 2023 and 2030, the global biodefense market valuation is expected to reach US$24.5 Bn by the end of...
Future Market Insights.png
Biodefense Market Sales are Estimated to Cross US$ 32.99 billion by 2033, Rise in Sales for Vaccines Surges the Demand for Biodefense | Future Market Insights, Inc. DUBAI, United Arab Emirates, Feb. 15, 2023 (GLOBE NEWSWIRE) -- It is estimated that the Biodefense Market is anticipated to reach US$ 32.99 billion by 2033 after being valued at US$ 16.31 billion in...
ARC logo.png
Biodefense Market Value Anticipated To Reach US$ 19.1 Billion By 2027: Acumen Research And Consulting
31 mars 2021 13h06 HE | Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Biodefense Market– Global Industry Analysis, Market Size, Opportunities and...
CytoDel Announces Pre-Clinical Data on Cyto-111 as Antidote to Botulinum Neurotoxin (BoNT) Published in Science Translational Medicine
07 janv. 2021 06h00 HE | CytoDel Inc
Studies Show Cyto-111 Enables Delivery of Antibodies to Previously Inaccessible Intraneuronal Targets without the need for a Viral Vector or Transfection Supports the Development of New Approaches to...
Biodefense Market by
Biodefense Market by Type and Application - Global Industry Analysis and Forecast To 2022
21 nov. 2017 06h49 HE | Crystal Market Research
LAS VEGAS, Nov. 21, 2017 (GLOBE NEWSWIRE) -- The latest trending report published by Crystal Market Research titled, Biodefense Market, approximates that the Biodefense Market size is estimated to...
PositiveID Corporati
PositiveID Corporation Announces 2015 Highlights and 2016 Outlook
11 janv. 2016 08h30 HE | PositiveID Corporation
DELRAY BEACH, Fla., Jan. 11, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today...
PositiveID Corporati
PositiveID Corporation to Present at the SeeThruEquity Microcap Healthcare Investor Conference on January 11, 2016
05 janv. 2016 08h30 HE | PositiveID Corporation
DELRAY BEACH, Fla., Jan. 05, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences tools and diagnostics company, announced today that its...
PositiveID Corporati
PositiveID Corporation Meets Major Development Milestone: New Firefly Dx Prototype With Real-Time Optics for Pathogen Detection
12 oct. 2015 08h30 HE | PositiveID Corporation
DELRAY BEACH, Fla., Oct. 12, 2015 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced...